Air Liquide : Home Healthcare acquisition in Australia

  Air Liquide : Home Healthcare acquisition in Australia

Business Wire

PARIS -- May 17, 2013

Regulatory News:

Air Liquide (Paris:AI) continues the development of its home healthcare
activity with the acquisition in Australia of a 73.3% share of Healthy Sleep
Solutions. This company is a leading player in the field of diagnosis and
treatment for patients with sleep disorders, notably sleep apnea.

Founded in 2007 in Australia, Healthy Sleep Solutions is specialized in sleep
apnea diagnosis and treatment at the patient’s home. Through its global
solutions, it provides sleep apnea patients with effective Continuous Positive
Airway Pressure treatment, helping them improve their quality of life.

In Australia, it is estimated that around 600,000people suffer from sleep
apnea, of which only 25% have been diagnosed to date. In 2012, Healthy Sleep
Solutions has taken care of over 10,000 patients in Australia with the support
of a team of 15employees and a network of 75 technicians. The company has
developed a strong relationship with an extensive number of local sleep
physicians, Specialists and General Practitioners.

Relying on sleep diagnosis at home and in laboratories, Air Liquide will now
provide in Australia complete quality care services for patients with mild to
severe sleep disorders.

Air Liquide intends to pursue Healthy Sleep Solutions’ development by
favouring the continuity of the company’s management, led by Marjan Mikel and
Stephen Newton, and by relying upon the expertise and commitment of its teams.

Pascal Vinet, Vice President, Healthcare Global Operations and member of the
Air Liquide Group Executive Committee, commented: “We are delighted to welcome
these new employees into the Group and to be able to benefit from their
expertise and dedication. After the acquisition of a majority share in the
company Snore Australia, a major player in the field of sleep diagnosis, this
new acquisition will reinforce our leading position in sleep apnea management
in Australia. This acquisition is in line with our growth strategy in
homehealthcare which aims at extending our international network to new,
high-potential markets. Health is a growth driver for Air Liquide.”

Air Liquide Healthcare
Air Liquide Healthcare supplies medical gases, home healthcare services,
hygiene products, medical equipment and specialty ingredients.
In 2012, it served over 7,500hospitals and 1 millionpatients at home
throughout the world.
The Group’s Healthcare business reached € 2,482million in revenues in 2012,
with 10,000employees.

Air Liquide in Australia
Entering Australia in 1957, Air Liquide now employs over 500 employees. The
Group operates at over 100 sites and serves more than 80,000 customers in most
industries and healthcare.

Home healthcare
Air Liquide, European leader and 3^rd worldwide in home healthcare, provides
home healthcare services in compliance with medical prescription for patients
suffering from chronic diseases such as COPD (Chronic Obstructive Pulmonary
Disease), sleep apnea and diabetes. These home healthcare services are being
developed in addition to hospital care, enabling patients to enjoy better
quality of life and local authorities to reduce costs.
Home Healthcare represents 43% of AirLiquide’s total 2012 Healthcare revenue.

Air Liquide is the world leader in gases for industry, health and the
environment, and is present in 80countries with close to 50,000employees.
Oxygen, nitrogen, hydrogen and rare gases have been at the core of Air
Liquide’s activities since its creation in 1902. Using these molecules, Air
Liquide continuously reinvents its business, anticipating the needs of current
and future markets. The Group innovates for the good of society while
delivering profitable growth and consistent performance.

Innovative technologies that curb polluting emissions, lower industry’s energy
use, recover and reuse natural resources or develop the energies of tomorrow,
such as hydrogen, biofuels or photovoltaic energy… Oxygen for hospitals, home
healthcare, fighting nosocomial infections… Air Liquide combines many products
and technologies to develop valuable applications and services not only for
its customers but also for society.

A partner for the long term, Air Liquide relies on employee commitment,
customer trust and shareholder support to pursue its vision of sustainable,
competitive growth. The diversity of Air Liquide’s teams, businesses, markets
and geographic presence provides a solid and sustainable base for its
development and strengthens its ability to push back its own limits, conquer
new territories and build its future.

Air Liquide explores the best that air can offer to preserve life, staying
true to its Corporate Social Responsibility and sustainable development
approach. In 2012, the Group’s revenues amounted to €15.3billion of which
82% were generated outside France. AirLiquide is listed on the Paris Euronext
stock exchange (compartment A) and is a member of the CAC 40 and Dow Jones
Euro Stoxx 50 indexes.

                              www.airliquide.com

                    Follow us on Twitter @AirLiquideGroup

Contact:

Air Liquide
Corporate Communications
Corinne Estrade-Bordry, + 33 (0)1 40 62 51 31
Garance Bertrand, + 33 (0)1 40 62 59 62
or
Investor Relations
Virginia Jeanson, +33 (0) 1 40 62 57 37
Annie Fournier, +33 (0) 1 40 62 57 18
or
Communication Air Liquide Healthcare
Muriel Doucet, + 33 (0)1 49 69 46 46